Mindfulness Meditation in Bone Marrow Transplantation

Sponsor
Emory University (Other)
Overall Status
Completed
CT.gov ID
NCT00165282
Collaborator
Dana-Farber Cancer Institute (Other), University of Massachusetts, Worcester (Other)
241
3
3
74
80.3
1.1

Study Details

Study Description

Brief Summary

The main purpose of this study is to examine techniques to help patients cope better with the stem cell/bone marrow transplant procedure.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness training
  • Behavioral: Nurse education
Phase 2/Phase 3

Detailed Description

Patients will be assigned to one of three study groups:
  1. receives the normal standard care;

  2. meets with an oncology nurse educator, in addition to the regular nurses on the transplant team. The nurse educator will provide information and answers to patient's questions about the stem cell/bone marrow transplant experience; or

  3. is taught mindfulness meditation by a nurse who is trained to be a mindfulness instructor and by an audio CD.

Mindfulness meditation is a technique that may help in coping with the stress and difficulties associated with cancer and undergoing a stem cell/bone marrow transplant. It involves learning to be in the present moment by paying attention to your breathing, sights, and sounds, and to sensations you may be experiencing, or thoughts and feelings you may be having.

Mindfulness meditation has been shown to be helpful to patients in the clinic who have cancer and other medical conditions.

Patients, regardless of random group assignment, will complete a questionnaire 8 different times, from before they are admitted to the hospital until 6 months after discharge.

Patients will also provide two urine samples while in the hospital to measure the levels of stress hormones present in the urine.

Study Design

Study Type:
Interventional
Actual Enrollment :
241 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
Mindfulness Meditation in Bone Marrow Transplantation
Study Start Date :
Apr 1, 2005
Actual Primary Completion Date :
Jan 1, 2010
Actual Study Completion Date :
Jun 1, 2011

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual Care

Normal standard of care

Active Comparator: Nurse education

Meets with oncology nurse

Behavioral: Nurse education
Meets with oncology nurse to have questions answered about medical treatments and side effects

Experimental: Mindfulness training

Taught Mindfulness meditation

Behavioral: Mindfulness training
Taught mindfulness meditation by mindfulness instructor (trained health care professional/RN) and audio c/d

Outcome Measures

Primary Outcome Measures

  1. Psychological functioning [1 year]

Secondary Outcome Measures

  1. Number of days to bone marrow engraftment [1 year]

  2. Medication use [1 year]

  3. Urinary stress hormones (cortisol and catecholamines) [1 year]

  4. Transplant related complications [1 year]

  5. Hospital length of stay and re-hospitalizations [1 year]

  6. Physical symptoms [1 year]

  7. Quality of life [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Autologous stem cell transplantation for hematologic malignancy

  • First transplant

  • 21 years of age or older

  • Speaks and understands English

Exclusion Criteria:
  • Planned tandem (more than one) transplant

  • Taking corticosteroids on a regular basis for a chronic condition

  • Prior formal mindfulness meditation training

  • Significant cognitive impairment and/or confirmed psychosis or thought disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Emory University Atlanta Georgia United States
2 Dana-Farber Cancer Institute Boston Massachusetts United States 02115
3 University of Massachusetts Medical School Worcester Massachusetts United States 01655

Sponsors and Collaborators

  • Emory University
  • Dana-Farber Cancer Institute
  • University of Massachusetts, Worcester

Investigators

  • Principal Investigator: Susan Bauer-Wu, PhD, Emory University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Susan Bauer-Wu, PhD, RN, FAAN, Professor, University of Virginia
ClinicalTrials.gov Identifier:
NCT00165282
Other Study ID Numbers:
  • IRB00005285
First Posted:
Sep 14, 2005
Last Update Posted:
Nov 28, 2013
Last Verified:
Nov 1, 2013
Keywords provided by Susan Bauer-Wu, PhD, RN, FAAN, Professor, University of Virginia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 28, 2013